Lonza Group Ag Operating Income 2012-2023 | LZAGY

Lonza Group Ag annual/quarterly operating income history and growth rate from 2012 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Lonza Group Ag operating income for the quarter ending December 31, 2023 was $M, a NAN% increase year-over-year.
  • Lonza Group Ag operating income for the twelve months ending December 31, 2023 was $0M, a NAN% increase year-over-year.
  • Lonza Group Ag annual operating income for 2023 was $0.98B, a 39.3% decline from 2022.
  • Lonza Group Ag annual operating income for 2022 was $1.615B, a 73.43% increase from 2021.
  • Lonza Group Ag annual operating income for 2021 was $0.931B, a 3.11% decline from 2020.
Lonza Group Ag Annual Operating Income
(Millions of US $)
2023 $980
2022 $1,615
2021 $931
2020 $961
2019 $978
2017 $735
2016 $493
2015 $445
2014 $463
2013 $273
2012 $357
2011 $296
Lonza Group Ag Quarterly Operating Income
(Millions of US $)
2023-12-31
2023-06-30
2022-12-31
2022-06-30
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2019-06-30
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2015-06-30
2014-12-31
2014-06-30
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
2011-06-30
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $40.585B $7.478B
Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $180.765B 23.67
Stryker (SYK) United States $129.618B 31.05
Boston Scientific (BSX) United States $112.981B 35.99
Medtronic (MDT) Ireland $100.927B 15.11
EssilorLuxottica (ESLOY) France $99.128B 0.00
Haleon (HLN) United Kingdom $37.716B 27.53
ResMed (RMD) United States $28.121B 26.40
Terumo (TRUMY) Japan $24.403B 34.46
Koninklijke Philips (PHG) Netherlands $22.841B 18.13
Zimmer Biomet Holdings (ZBH) United States $22.328B 14.26
Baxter (BAX) United States $17.045B 12.12
Insulet (PODD) United States $14.134B 62.67
Smith & Nephew SNATS (SNN) United Kingdom $10.833B 0.00
Demant (WILYY) Denmark $9.370B 0.00
Bio-Rad Laboratories (BIO) United States $7.790B 25.48
BellRing Brands (BRBR) United States $7.453B 35.06
Lantheus Holdings (LNTH) United States $5.565B 13.87
GN Store Nord (GNNDY) Denmark $4.222B 23.71
Haemonetics (HAE) United States $4.215B 20.79
Perrigo (PRGO) Ireland $3.501B 10.61
Prestige Consumer Healthcare (PBH) United States $3.437B 16.35
Neogen (NEOG) United States $3.386B 32.56
ICU Medical (ICUI) United States $2.893B 25.54
Envista Holdings (NVST) United States $2.858B 11.79
TG Therapeutics (TGTX) United States $2.749B 77.35
Green Thumb Industries (GTBIF) United States $2.552B 49.96
Agios Pharmaceuticals (AGIO) United States $2.448B 0.00
QuidelOrtho (QDEL) United States $2.225B 12.35
LeMaitre Vascular (LMAT) United States $1.847B 54.13
Maravai LifeSciences Holdings (MRVI) United States $1.804B 0.00
Warby Parker (WRBY) United States $1.592B 0.00
InMode (INMD) Israel $1.532B 8.14
AdaptHealth (AHCO) United States $1.332B 9.90
Verano Holdings (VRNOF) United States $1.246B 0.00
AtriCure (ATRC) United States $1.084B 0.00
Owens & Minor (OMI) United States $1.033B 9.00
National Vision Holdings (EYE) United States $1.028B 32.72
BioLife Solutions (BLFS) United States $0.987B 0.00
Cresco Labs (CRLBF) United States $0.771B 0.00
Phibro Animal Health (PAHC) United States $0.679B 14.46
Evolus (EOLS) United States $0.679B 0.00
PetIQ (PETQ) United States $0.656B 21.21
VAREX IMAGING (VREX) United States $0.602B 14.16
Surmodics (SRDX) United States $0.599B 37.54
Quanterix (QTRX) United States $0.506B 0.00
ZimVie (ZIMV) United States $0.498B 42.44
Canopy Growth (CGC) Canada $0.491B 0.00
Valneva SE (VALN) France $0.488B 0.00
Biote (BTMD) United States $0.463B 10.67
Jin Medical (ZJYL) China $0.403B 0.00
TerrAscend (TSNDF) Canada $0.394B 0.00
Cerus (CERS) United States $0.325B 0.00
OraSure Technologies (OSUR) United States $0.315B 10.14
Zynex (ZYXI) United States $0.296B 40.52
MacroGenics (MGNX) United States $0.266B 0.00
Viemed Healthcare (VMD) United States $0.254B 25.19
Aurora Cannabis (ACB) Canada $0.252B 0.00
Sanara MedTech (SMTI) United States $0.243B 0.00
Utah Medical Products (UTMD) United States $0.236B 14.85
Omeros (OMER) United States $0.235B 0.00
Ayr Wellness (AYRWF) United States $0.233B 0.00
High Tide (HITI) Canada $0.178B 0.00
Organigram Holdings (OGI) Canada $0.160B 0.00
FitLife Brands (FTLF) United States $0.153B 21.76
Capricor Therapeutics (CAPR) United States $0.153B 0.00
TriSalus Life Sciences (TLSI) United States $0.150B 0.00
Quipt Home Medical (QIPT) United States $0.137B 0.00
Veru (VERU) United States $0.123B 0.00
Jushi Holdings (JUSHF) United States $0.110B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.104B 0.00
Fonar (FONR) United States $0.101B 10.26
Brainsway (BWAY) Israel $0.101B 0.00
InterCure (INCR) Israel $0.092B 15.46
Cellectar Biosciences (CLRB) United States $0.090B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.073B 4.75
MariMed (MRMD) United States $0.069B 0.00
Safety Shot (SHOT) United States $0.060B 0.00
Rockwell Medical (RMTI) United States $0.053B 0.00
Modular Medical (MODD) United States $0.051B 0.00
Zevia PBC (ZVIA) United States $0.049B 0.00
Bright Green (BGXX) United States $0.048B 0.00
Allurion Technologies (ALUR) United States $0.048B 0.00
Apyx Medical (APYX) United States $0.046B 0.00
United-Guardian (UG) United States $0.041B 14.90
Cytosorbents (CTSO) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Exagen (XGN) United States $0.032B 0.00
Nephros (NEPH) United States $0.022B 0.00
Meihua Medical Technologies (MHUA) China $0.021B 0.00
Agape ATP (ATPC) $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.016B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
GUARDION HEALTH (GHSI) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.012B 0.00
GlucoTrack (GCTK) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
FSD PHARMA (HUGE) Canada $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Lucy Scientific Discovery (LSDI) Canada $0.001B 0.00
Akanda (AKAN) United Kingdom $0.001B 0.00
Smart For Life (SMFL) United States $0.000B 0.00
SNDL (SNDL) Canada $0.000B 0.00